Mitochondrial Contribution to Parkinson's Disease Pathogenesis

The identification of the etiologies and pathogenesis of Parkinson's disease (PD) should play an important role in enabling the development of novel treatment strategies to prevent or slow the progression of the disease. The last few years have seen enormous progress in this respect. Abnormalit...

Full description

Saved in:
Bibliographic Details
Main Authors: Anthony H. V. Schapira, Matthew Gegg
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.4061/2011/159160
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683664923787264
author Anthony H. V. Schapira
Matthew Gegg
author_facet Anthony H. V. Schapira
Matthew Gegg
author_sort Anthony H. V. Schapira
collection DOAJ
description The identification of the etiologies and pathogenesis of Parkinson's disease (PD) should play an important role in enabling the development of novel treatment strategies to prevent or slow the progression of the disease. The last few years have seen enormous progress in this respect. Abnormalities of mitochondrial function and increased free radical mediated damage were described in post mortem PD brain before the first gene mutations causing familial PD were published. Several genetic causes are now known to induce loss of dopaminergic cells and parkinsonism, and study of the mechanisms by which these mutations produce this effect has provided important insights into the pathogenesis of PD and confirmed mitochondrial dysfunction and oxidative stress pathways as central to PD pathogenesis. Abnormalities of protein metabolism including protein mis-folding and aggregation are also crucial to the pathology of PD. Genetic causes of PD have specifically highlighted the importance of mitochondrial dysfunction to PD: PINK1, parkin, DJ-1 and most recently alpha-synuclein proteins have been shown to localise to mitochondria and influence function. The turnover of mitochondria by autophagy (mitophagy) has also become a focus of attention. This review summarises recent discoveries in the contribution of mitochondrial abnormalities to PD etiology and pathogenesis.
format Article
id doaj-art-d49b720ef5a84b2f9e345ddeef0aede5
institution DOAJ
issn 2042-0080
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-d49b720ef5a84b2f9e345ddeef0aede52025-08-20T03:23:46ZengWileyParkinson's Disease2042-00802011-01-01201110.4061/2011/159160159160Mitochondrial Contribution to Parkinson's Disease PathogenesisAnthony H. V. Schapira0Matthew Gegg1Department of Clinical Neurosciences, UCL Institute of Neurology, Rowland Hill Street, London NW3 2PF, UKDepartment of Clinical Neurosciences, UCL Institute of Neurology, Rowland Hill Street, London NW3 2PF, UKThe identification of the etiologies and pathogenesis of Parkinson's disease (PD) should play an important role in enabling the development of novel treatment strategies to prevent or slow the progression of the disease. The last few years have seen enormous progress in this respect. Abnormalities of mitochondrial function and increased free radical mediated damage were described in post mortem PD brain before the first gene mutations causing familial PD were published. Several genetic causes are now known to induce loss of dopaminergic cells and parkinsonism, and study of the mechanisms by which these mutations produce this effect has provided important insights into the pathogenesis of PD and confirmed mitochondrial dysfunction and oxidative stress pathways as central to PD pathogenesis. Abnormalities of protein metabolism including protein mis-folding and aggregation are also crucial to the pathology of PD. Genetic causes of PD have specifically highlighted the importance of mitochondrial dysfunction to PD: PINK1, parkin, DJ-1 and most recently alpha-synuclein proteins have been shown to localise to mitochondria and influence function. The turnover of mitochondria by autophagy (mitophagy) has also become a focus of attention. This review summarises recent discoveries in the contribution of mitochondrial abnormalities to PD etiology and pathogenesis.http://dx.doi.org/10.4061/2011/159160
spellingShingle Anthony H. V. Schapira
Matthew Gegg
Mitochondrial Contribution to Parkinson's Disease Pathogenesis
Parkinson's Disease
title Mitochondrial Contribution to Parkinson's Disease Pathogenesis
title_full Mitochondrial Contribution to Parkinson's Disease Pathogenesis
title_fullStr Mitochondrial Contribution to Parkinson's Disease Pathogenesis
title_full_unstemmed Mitochondrial Contribution to Parkinson's Disease Pathogenesis
title_short Mitochondrial Contribution to Parkinson's Disease Pathogenesis
title_sort mitochondrial contribution to parkinson s disease pathogenesis
url http://dx.doi.org/10.4061/2011/159160
work_keys_str_mv AT anthonyhvschapira mitochondrialcontributiontoparkinsonsdiseasepathogenesis
AT matthewgegg mitochondrialcontributiontoparkinsonsdiseasepathogenesis